Mangoceuticals, Inc.

NasdaqCM MGRX

Mangoceuticals, Inc. Cash and Short-Term Investments for the quarter ending September 30, 2024: USD 73.91 K

Mangoceuticals, Inc. Cash and Short-Term Investments is USD 73.91 K for the quarter ending September 30, 2024. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

NasdaqCM: MGRX

Mangoceuticals, Inc.

CEO	Mr. Jacob D. Cohen
IPO Date	March 21, 2023
Location	United States
Headquarters	15110 North Dallas Parkway
Employees	3
Sector	Health Care
Industries Telehealth Pharmaceuticals

Description

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Key trends

Past 5 years